Patents by Inventor Christophe Arnoult

Christophe Arnoult has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for increasing the lifespan and motility of animal sperm using an inhibitor of Slo3 potassium channel
    Publication number: 20230292743
    Abstract: The invention relates to a method for increasing the lifespan of animal sperm comprising contacting said sperm with an inhibitor of Slo3 potassium channel. The invention also relates to a use of an inhibitor of Slo3 potassium channel, for increasing the lifespan of animal sperm or motility of capacitated animal sperm, comprising contacting an inhibitor of Slo3 potassium channel with said sperm. Moreover, the invention relates to an artificial insemination instrument for use in artificial insemination of an animal, comprising animal sperm in contact with an inhibitor of Slo3 potassium channel. The invention also relates to a method for artificially inseminating an animal using said artificial insemination instrument. Eventually, the invention relates to a method for increasing the fertility of an animal, comprising contacting sperm of said animal with an inhibitor of Slo3 potassium channel; then artificially inseminating said animal with said sperm.
    Type: Application
    Filed: May 24, 2023
    Publication date: September 21, 2023
    Inventors: Christophe ARNOULT, Eric SCHMITT, Guillaume MARTINEZ, Jessica ESCOFFIER
  • Method for increasing the lifespan and motility of animal sperm using an inhibitor of Slo3 potassium channel
    Patent number: 11696579
    Abstract: The invention relates to a method for increasing the lifespan of animal sperm comprising contacting said sperm with an inhibitor of Slo3 potassium channel. The invention also relates to a use of an inhibitor of Slo3 potassium channel, for increasing the lifespan of animal sperm or motility of capacitated animal sperm, comprising contacting an inhibitor of Slo3 potassium channel with said sperm. Moreover, the invention relates to an artificial insemination instrument for use in artificial insemination of an animal, comprising animal sperm in contact with an inhibitor of Slo3 potassium channel. The invention also relates to a method for artificially inseminating an animal using said artificial insemination instrument. Eventually, the invention relates to a method for increasing the fertility of an animal, comprising contacting sperm of said animal with an inhibitor of Slo3 potassium channel; then artificially inseminating said animal with said sperm.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: July 11, 2023
    Assignees: IMV TECHNOLOGIES, UNIVERSITE GRENOBLE ALPES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), SWISSGENETICS
    Inventors: Christophe Arnoult, Eric Schmitt, Guillaume Martinez, Jessica Escoffier
  • Method for Increasing the Lifespan and Motility of Animal Serm Using an Inhibitor of Slo3 Potassium Channel
    Publication number: 20200315164
    Abstract: The invention relates to a method for increasing the lifespan of animal sperm comprising contacting said sperm with an inhibitor of Slo3 potassium channel. The invention also relates to a use of an inhibitor of Slo3 potassium channel, for increasing the lifespan of animal sperm or motility of capacitated animal sperm, comprising contacting an inhibitor of Slo3 potassium channel with said sperm. Moreover, the invention relates to an artificial insemination instrument for use in artificial insemination of an animal, comprising animal sperm in contact with an inhibitor of Slo3 potassium channel. The invention also relates to a method for artificially inseminating an animal using said artificial insemination instrument. Eventually, the invention relates to a method for increasing the fertility of an animal, comprising contacting sperm of said animal with an inhibitor of Slo3 potassium channel; then artificially inseminating said animal with said sperm.
    Type: Application
    Filed: December 18, 2018
    Publication date: October 8, 2020
    Inventors: Christophe ARNOULT, Eric SCHMITT, Guillaume MARTINEZ, Jessica ESCOFFIER
  • Use of La1-like peptide isolated from maurus palmatus venom as an activator of sperm motility in mammals
    Patent number: 10729745
    Abstract: The invention relates to a La-1-like peptide agent that increases sperm motility. It is non-toxic and it may be used to treat male infertility in humans, and also to increase fertility in animals. It may be used in artificial reproductive techniques such as in vitro fertilisation (IVF), including intra-cytoplasmic sperm injection (ICSI). The La-1 like peptide agent may also be used in artificial insemination techniques such as intra-cytoplasmic uterine injection (IUI).
    Type: Grant
    Filed: June 1, 2017
    Date of Patent: August 4, 2020
    Assignee: IMV TECHNOLOGIES
    Inventors: Christophe Arnoult, Eric Schmitt, Guillaume Martinez, Pierre Ray
  • USE OF LA1-LIKE PEPTIDE ISOLATED FROM MAURUS PALMATUS VENOM AS AN ACTIVATOR OF SPERM MOTILITY IN MAMMALS
    Publication number: 20190151412
    Abstract: The invention relates to a La-1-like peptide agent that increases sperm motility. It is non-toxic and it may be used to treat male infertility in humans, and also to increase fertility in animals. It may be used in artificial reproductive techniques such as in vitro fertilisation (IVF), including intra-cytoplasmic sperm injection (ICSI). The La-1 like peptide agent may also be used in artificial insemination techniques such as intra-cytoplasmic uterine injection (IUI).
    Type: Application
    Filed: June 1, 2017
    Publication date: May 23, 2019
    Inventors: Christophe ARNOULT, Eric SCHMITT, Guillaume MARTINEZ, Pierre RAY
  • Fertilization modulation compounds and process for implementing them
    Patent number: 8758746
    Abstract: This invention relates to fertilization modulation compounds and process for implementing them.
    Type: Grant
    Filed: March 24, 2010
    Date of Patent: June 24, 2014
    Assignees: Universite Joseph Fourier, Centre National de la Recherche Scientifique
    Inventors: Christophe Arnoult, Michel De Waard, Gerard Lambeau
  • HUMAN FERTILITY TEST USING DPY19L2
    Publication number: 20120283126
    Abstract: The present patent application concerns a method for diagnosing infertility related to the DPY19L2 protein, in a male human subject, and a method for treating said subject with a view to restoring fertility. The present invention also concerns the use of molecules inhibiting the action of the DPY19L2 polypeptide in a wild-type carrier male subject, for example of anti-DPY19L2 interfering nucleic acid type selectively inhibiting the expression of the DPY19L2 polypeptide.
    Type: Application
    Filed: November 10, 2010
    Publication date: November 8, 2012
    Applicant: UNIVERSITE JOSEPH FOURIER (GRENOBLE 1)
    Inventors: Pierre Ray, Christophe Arnoult
  • FERTILIZATION MODULATION COMPOUNDS AND PROCESS FOR IMPLEMENTING THEM
    Publication number: 20120034204
    Abstract: This invention relates to fertilization modulation compounds and process for implementing them.
    Type: Application
    Filed: March 24, 2010
    Publication date: February 9, 2012
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE JOSEPH FOURIER
    Inventors: Christophe Arnoult, Michel De Waard, Gerard Lambeau